Springer Nature's shares leap on Frankfurt debut
Springer Nature shares open at 24 euros each
Germany's first listing in six months
Opening is 6.7% above where shares were priced
Adds quotes in paragraph 10
By Lucy Raitano and Hakan Ersen
LONDON/FRANKFURT, Oct 4 (Reuters) -Springer Nature's SPGG.DE shares opened at 24 euros in its Frankfurt initial public offering (IPO) on Friday, 6.7% above where Germany's first listing in six months was priced.
Shares in the publisher of Nature and Scientific American were priced at 22.5 euros earlier this week, giving it a valuation of around 4.5 billion euros ($4.96 billion).
The shares rose as much as 9.6% from their IPO price to an intraday high of 24.66 euros, outperforming Germany's blue-chip DAX index .GDAXI which was trading flat and a basket of European media companies SXMP which was last 0.4% lower.
Springer Nature's IPO positive start will be a boost to other companies planning listings in Europe, after gains by new offerings this year from Swiss skincare firm Galderma GALD.S and private equity firm CVC Capital Partners CVC.AS.
CEO Frank Vrancken Peeters said his company had named the IPO project Skywalker, after the character in the Star Wars movies. "When the Force is with you, how can you not succeed?" he said ahead of trading at the Frankfurt Stock Exchange.
The company and its bankers set a price range of 21 euros to 23.50 euros per share for the IPO last week, implying a market capitalisation of up to 4.7 billion euros.
IPO order books were covered some 30 minutes after opening.
The publisher raised 200 million euros from the sale of new shares. The total offer size was set to be around 600 million euros, assuming the full exercise of a greenshoe option.
Primary proceeds from the listing are intended in part to reduce Springer Nature's debt.
"It's a strong vote of confidence from our global investor base for what we've done in the past and our expectations going forward," Vrancken Peeters told Reuters.
"We will continue to make sure that we accelerate solutions to the world's biggest problems," Vrancken Peeters said.
The CEO said the company aimed to unlock the potential of open access and make "sure that we take advantage of artificial intelligence to reduce friction in the academic community to work with us and to share our findings across the world".
Majority shareholder Holtzbrinck Publishing is expected to hold 50.6% of the shares and existing shareholders BC Partners around 36%, after selling some of its holding, after the IPO.
Springer Nature said it intends to pay a dividend of 25 million euros ($27.5 million) for this year, and thereafter an annual dividend of around 50% of annual adjusted net income.
Its annual report shows its financial leverage ratio has been cut to 2.9 times, from 4.6 times in 2019.
The transaction was led by Deutsche Bank DBKGn.DE, JPMorgan JPM.N and Morgan Stanley MS.N.
Springer Nature, which postponed its previous IPO plans in 2020 as a result of the COVID-19 pandemic, reported group revenue of 1.85 billion euros and adjusted operating profit of 511 million euros in 2023.
($1 = 0.9071 euros)
Reporting by Lucy Raitano and Hakan Ersen; Writing by Anousha Sakoui and Emma Victoria Farr; Editing by Amanda Cooper, David Evans and Alexander Smith
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
